Walkable streets tracked lower diabetes risk, but clearly only in richer areas

Walkable neighborhoods are one of the few health interventions a city can actually build. Pavements, crossings, shops within reach, streets laid out so that walking somewhere is plausible.

A study in Diabetes Care tested that against a group at unusually high risk: 12,403 New York women who had gestational diabetes, followed for up to 12 years.

Walkability tracked lower rates of type 2 diabetes. The clear version of that association appeared in the wealthiest neighborhoods and largely disappeared everywhere else.

Why women with gestational diabetes are the right group to study

Gestational diabetes is a type of diabetes that occurs only during pregnancy, and it can cause health problems in both mother and baby.

It usually clears after the birth, which is why it gets treated as an episode rather than a warning. It is a warning. If you had gestational diabetes, you are more likely to develop type 2 diabetes, and your child is more likely to have obesity or develop type 2 diabetes.

The scale of that risk shows up plainly here. Among 12,403 women with GDM, or gestational diabetes mellitus, at baseline, the 12-year cumulative incidence of type 2 diabetes was 20.6%.

One in five, inside twelve years of a pregnancy. That is a group where prevention has somewhere to work, and where the standard advice is behavioral: you may be able to lower your and your child’s chances of developing these problems by reaching a healthy weight, making healthy food choices, and being physically active.

Behavior happens somewhere, which is the question this study asks.

How you measure a walkable street

The researchers identified women with gestational diabetes who delivered in New York City in 2009-2011 through birth certificate records and hospital discharge data, and linked them to the city A1C Registry data (2009-2021) for follow-up.

The outcome is a laboratory value rather than a diagnosis. Type 2 diabetes was ascertained as two A1C results at or above 6.5% after 12 weeks postpartum. A1C is the blood test that reflects average blood sugar over the preceding months.

For the exposure, a previously published neighborhood walkability index was split into four equal groups. Such indexes combine things like population density, how the streets connect, and the mix of shops and homes. They describe the shape of a place, not what is inside it.

What walkability tracked

The headline numbers are modest and oddly shaped.

Rates of type 2 diabetes for low-medium, medium, and high walkability, set against low, were protective or null. Protective or null is the authors’ own phrasing and it is accurate: the estimates sit below 1 without clearly separating from it.

The shape is the part that should slow a reader down. The middle category scored best, and both the category above and the one below reached past no difference at their upper edges. More walkable was not steadily better.

Then the stratified analysis, which is where the story is. The protective association from high walkability was observed only in the most affluent neighborhoods, at roughly half the rate of diabetes seen in the least walkable areas.

Why the walkability benefit might be conditional

The paper does not test why, and the candidate explanations are not hard to generate.

A walkability index counts whether destinations are reachable on foot, and stops there. A dense street of takeaways and a dense street with a grocery store score similarly and do different things to a person’s blood sugar.

Nor does it capture whether walking there feels safe, or is pleasant, or is possible around a job with fixed hours and a commute.

So one honest reading is that walkability is necessary and not sufficient: the street layout enables walking, and whether that turns into health depends on what the walking reaches. The authors stop at the observation itself, concluding that associations depended on individual and neighborhood socioeconomic contexts.

What this walkability study cannot establish

This is observational, and people do not land in neighborhoods at random. Women who live in affluent, walkable areas differ from women who do not in income, work, health care access and much else that adjustment cannot fully remove.

The stratified result also comes from a subgroup, where estimates are less stable and chance findings are commoner. Its range is wide.

The cohort is one city over one period, and New York’s walkability is not most places’ walkability. The paper is paywalled, so the authors’ own limitations section was not available for this piece.

What follows for city planning and for diabetes

The authors resist the easy conclusion, and their caution is the useful part: while increasing walkability is a core planning goal and may improve health, decisions should also address neighborhood inequities in diabetes.

Building pavements in a poor neighborhood, on this evidence, does not by itself deliver the benefit seen in a rich one. That is an argument for doing more rather than less.

For an individual who had gestational diabetes, the actionable finding is the plainer one at the top: a fifth of this cohort developed type 2 diabetes within twelve years. Physical activity contributes to the prevention and management of noncommunicable diseases such as cardiovascular diseases, cancer and diabetes, and a periodic blood sugar check after that pregnancy is worth raising with a doctor.

There is a window before that, too. Supervised exercise during pregnancy cut gestational diabetes risk by around a quarter across nineteen randomized trials.